Watch Ticker

Cyclacel Pharmaceuticals, Inc

Go to Cyclacel Pharmaceuticals, Inc Website

$8.11

-0.10 (-1.22%)

Live

Previous Close

$8.21

Day Range

$0 - $0

Previous Day Range

$7.91 - $10.58

Market Cap

$15.6 million USD

Day Vol.

Previous Day Vol.

1.6 million

Currency

USD

Primary Exchange

Nasdaq

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including C...

Community

0 posts discussing

0

Watchers

1

Visitors

Recent News

Cyclacel Pharmaceuticals - CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

Cyclacel Pharmaceuticals reported preclinical study findings demonstrating that biliary tract cancer cells are sensitive to plogosertib, a PLK1 inhibitor, with potential for targeted cancer treatment using BUBR1 as a biomarker.

Related tickers: CYCC, CYCCP.

Read Full Article

Datuk Dr. Doris Wong Sing Ee - CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT

Cyclacel Pharmaceuticals has amended an exchange agreement with FITTERS Diversified Berhad to acquire all ordinary shares of Fitters Sdn. Bhd., issuing 19.99% of its stock and paying $1 million, with the transaction subject to stockholder approvals.

Related tickers: CYCC, CYCC.P, CYCCP.

Read Full Article

Trending Tickers

Please sign in to view